Login to Your Account


Scioderm seeks fast track with breakthrough drug for rare skin disorder

By Jennifer Boggs
Managing Editor

Monday, April 21, 2014
"The worst disease you've never heard of." That's how patient advocacy and nonprofit group Debra (Dystrophic Epidermolysis Bullosa Research Association of America) refer to epidermolysis bullosa (EB), a rare genetic disorder characterized by fragile skin that it often leaves its sufferers with chronic open wounds and blisters.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription